ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.5624T>G (p.Val1875Gly)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV003471679 SCV004204703 likely pathogenic Polycystic kidney disease 4 2023-03-21 criteria provided, single submitter clinical testing
Invitae RCV003502740 SCV004293756 likely pathogenic Autosomal recessive polycystic kidney disease 2022-11-24 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function. This missense change has been observed in individuals with polycystic kidney disease (PMID: 19914852, 27752906). This variant is present in population databases (rs202016058, gnomAD 0.0009%). This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 1875 of the PKHD1 protein (p.Val1875Gly).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.